That is essential, due to the fact that the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work. To put it simply, we need to know how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error process (angel investor). However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're designed to do. This was a breakthrough practically nobody noticed. However it's going to have profound implications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be plenty of investment chances in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown stock predictions). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it pulled back possibly considerably prior to going greater - jeff brown biotech genome sequencing. I have actually been covering bitcoin for a long time now. One of the very first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly educating readers. But that's not the big concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. future report. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many fantastic private companies on the edge of hitting the general public markets And I've been dealing with a new method for you to invest even prior to these business go public.
This opportunity has actually been developing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to reserve your spot for complimentary.
Emma Walsh here, managing editor of the Journal. Regular Diary readers understand that tech isn't our normal beat (exponential tech investor). And when it concerns tech investing, we leave it to the specialists. The good news is, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we know (jeff brown genetic sequencing stock). In reality, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge photo and anticipate what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and far more. These patterns are experiencing rapid growth and creating extraordinary chances for financiers. I want to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown prediction. However in spite of what numerous readers may think, this is a trend that's simply starting. Even though the COVID-19 pandemic disrupted supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (exponential tech investor). Losing 2 months of production and sales actually impacts how lots of 5G devices are offered in the calendar year. When you think about all of that, selling 250 million systems is amazing. More significantly, the delays triggered by the pandemic created a load of pent-up need. And that need is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G gadgets will be shipped in 2021 - genetic sequencing companies jeff brown. And that's not my only 5G prediction When I have actually spoken about 5G in the past, I have actually described its three various stages.
In Stage Two, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services begin to be provided (jeff brown investment prediction). That's when we begin to see applications running on 5G networks. Believe of things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Phase Three by this summer. This starts something of a virtuous cycle: A lot of people do not actually appreciate the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In reality, 5G is going to open a suite of amazing applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment opportunities moving forward will be enormous. Stepping far from 5G, the next crucial innovation I foresee in 2021 is CRISPR hereditary modifying. CRISPR means "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For years, CRISPR was mainly a niche innovation that wasn't well understood. And throughout that time, there were actually just three business operating in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing real results. We're dealing with diseases and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering amazing returns. This whole industry is effectively a greenfield opportunity.
There's space for lots of business to exist in this space. jeff brown top biotech stock 2021. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or three more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things taking place at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can properly forecast the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is very important because the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has been a trial-and-error process. However now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but several drug treatments produced utilizing this innovation. This was among those advancements that nearly nobody noticed. However it's going to have extensive implications for treating illness. And, naturally, there will be lots of financial investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back possibly substantially prior to going higher. I've been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - biotech stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. black sea. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information is up to date since February 2021, however we could not independently confirm this claim. Provided Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to choose winning technology stocks. He invested more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional perspective on the marketplace. He's always on the hunt for new opportunities, and he shares a lot of his best picks in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully predicted some of the most significant financial events of the previous twenty years. Although he doesn't appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it ideal every time, however Jeff Brown's accurate predictions have earned him legions of devoted fans. That says a lot about his ability. The Near Future Report is published by Brownstone Research study, a prominent financial research publisher. Brownstone Research provides several research study services with a wide array of specializations - jeff brown genetic sequencing stock.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - exponential growth. On its website, Brownstone says its mission is to offer retail financiers with professional-grade research study: "For too long, the finest financial investment research has actually not been available to specific investors. It has been typically reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. brownstone research. The mission of Brownstone Research study is to make that sort of proprietary research study available to any investors aiming to gain an edge in the markets. The objective is easy to provide special and lucrative investment research found nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also serves as the firm's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you understand even a bit about the marketplace, you know that he has a credibility as a King Midas of sorts. jeff brown tech stock 2021. Whatever he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In truth, Brown believes S.A.V. first lady. could be "the biggest pattern of the 2020s, and he's not alone. Examine out these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying two innovative technologies: expert system and electrical cars and trucks. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing short of the vehicle market's Holy Grail. As you know, electrical automobiles and self-driving car stocks have been substantial this year, however the Wall Street machine has actually approved hype without much concrete outcome. Regardless of a drastic increase in competitors over the previous few years, Brown still believes Musk has the very best opportunity of putting it all together.
tech could be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Lorry, and it might be the future of transportation. Basically, this technology would permit you to lease your automobile as a self-governing, self-driving taxi when you're not utilizing it. You just get out of the vehicle and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a large piece of the revenues. It sounds crazy, however it might be closed than you believe.